| Photodynamic therapy with fullerenes P Mroz, GP Tegos, H Gali, T Wharton, T Sarna, MR Hamblin Photochemical & Photobiological Sciences 6 (11), 1139-1149, 2007 | 382 | 2007 |
| Cationic fullerenes are effective and selective antimicrobial photosensitizers GP Tegos, TN Demidova, D Arcila-Lopez, H Lee, T Wharton, H Gali, ... Chemistry & biology 12 (10), 1127-1135, 2005 | 335 | 2005 |
| Functionalized fullerenes mediate photodynamic killing of cancer cells: Type I versus Type II photochemical mechanism P Mroz, A Pawlak, M Satti, H Lee, T Wharton, H Gali, T Sarna, ... Free Radical Biology and Medicine 43 (5), 711-719, 2007 | 316 | 2007 |
| Novel series of 111In-labeled bombesin analogs as potential radiopharmaceuticals for specific targeting of gastrin-releasing peptide receptors expressed on human prostate … TJ Hoffman, H Gali, CJ Smith, GL Sieckman, DL Hayes, NK Owen, ... Journal of Nuclear Medicine 44 (5), 823-831, 2003 | 213 | 2003 |
| 99mTc-labeling and in vivo studies of a bombesin analogue with a novel water-soluble dithiadiphosphine-based bifunctional chelating agent SR Karra, R Schibli, H Gali, KV Katti, TJ Hoffman, C Higginbotham, ... Bioconjugate chemistry 10 (2), 254-260, 1999 | 171 | 1999 |
| Design and Development of Functionalized Water‐Soluble Phosphines: Catalytic and Biomedical Implications KV Katti, H Gali, CJ Smith, DE Berning Accounts of Chemical Research 32 (1), 9-17, 1999 | 166 | 1999 |
| Radiochemical investigations of 177Lu-DOTA-8-Aoc-BBN [7-14] NH2: an in vitro/in vivo assessment of the targeting ability of this new radiopharmaceutical for PC-3 human prostate … CJ Smith, H Gali, GL Sieckman, DL Hayes, NK Owen, DG Mazuru, ... Nuclear medicine and biology 30 (2), 101-109, 2003 | 162 | 2003 |
| Radiochemical Investigations of 99mTc−N3S-X-BBN[7−14]NH2: An in Vitro/in Vivo Structure−Activity Relationship Study Where X = 0-, 3-, 5-, 8-, and 11-Carbon … CJ Smith, H Gali, GL Sieckman, C Higginbotham, WA Volkert, TJ Hoffman Bioconjugate chemistry 14 (1), 93-102, 2003 | 153 | 2003 |
| Antimicrobial photodynamic therapy with functionalized fullerenes: quantitative structure-activity relationships K Mizuno, T Zhiyentayev, L Huang, S Khalil, F Nasim, GP Tegos, H Gali, ... Journal of nanomedicine & nanotechnology 2 (2), 1, 2011 | 106 | 2011 |
| Synthesis, characterization, and labeling with 99mTc/188Re of peptide conjugates containing a dithia-bisphosphine chelating agent H Gali, TJ Hoffman, GL Sieckman, NK Owen, KV Katti, WA Volkert Bioconjugate chemistry 12 (3), 354-363, 2001 | 98 | 2001 |
| Chemodrug delivery using integrin-targeted PLGA-Chitosan nanoparticle for lung cancer therapy A Babu, N Amreddy, R Muralidharan, G Pathuri, H Gali, A Chen, YD Zhao, ... Scientific reports 7 (1), 14674, 2017 | 97 | 2017 |
| Photosensitizers for targeted photodynamic therapy T Wharton, H Gali, MR Hamblin US Patent 8,207,211, 2012 | 71 | 2012 |
| Therapeutic and diagnostic targeting of cancers cells with tumor homing peptides G Sieckman, W Volkert, L Forte, T Hoffman, H Gali US Patent App. 10/371,966, 2003 | 67 | 2003 |
| Facile ring-opening reactions of phthalimides as a new strategy to synthesize amide-functionalized phosphonates, primary phosphines, and bisphosphines H Gali, KR Prabhu, SR Karra, KV Katti The Journal of Organic Chemistry 65 (3), 676-680, 2000 | 66 | 2000 |
| Unprecedented selective aminolysis: Aminopropyl phosphine as a building block for a new family of air stable mono-, bis-, and tris-primary phosphines KR Prabhu, N Pillarsetty, H Gali, KV Katti Journal of the American Chemical Society 122 (7), 1554-1555, 2000 | 51 | 2000 |
| Small-molecule inhibition of GCNT3 disrupts mucin biosynthesis and malignant cellular behaviors in pancreatic cancer CV Rao, NB Janakiram, V Madka, G Kumar, EJ Scott, G Pathuri, T Bryant, ... Cancer research 76 (7), 1965-1974, 2016 | 49 | 2016 |
| meso-Substituted octabromoporphyrins: synthesis, spectroscopy, electrochemistry and electronic structure G Hariprasad, S Dahal, BG Maiya Journal of the Chemical Society, Dalton Transactions, 3429-3436, 1996 | 49 | 1996 |
| A “dose on demand” Biomarker Generator for automated production of [18 F] F− and [18F] FDG V Awasthi, J Watson, H Gali, G Matlock, A McFarland, J Bailey, ... Applied Radiation and Isotopes 89, 167-175, 2014 | 44 | 2014 |
| Early Detection and Prevention of Pancreatic Cancer: Use of Genetically Engineered Mouse Models and advanced Imaging Technologies A Mohammed, N B Janakiram, S Lightfoot, H Gali, A Vibhudutta, C V Rao Current Medicinal Chemistry 19 (22), 3701-3713, 2012 | 44 | 2012 |
| Design and Development of the First Peptide‐Chelating Bisphosphane Bioconjugate from a Novel Functionalized Phosphorus (III) Hydride Synthon H Gali, SR Karra, VS Reddy, KV Katti Angewandte Chemie International Edition 38 (13‐14), 2020-2023, 1999 | 44 | 1999 |
